Dalfampridine

Product NDC
16729-292
11-digit product format
167290292
Labeler code
16729
Product ID
16729-292_40bc3607-8ee1-5a56-e063-6294a90a3b3b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Dalfampridine
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Accord Healthcare Inc.
Application
ANDA206863
Marketing category
ANDA
Marketing start
2018-09-18
Substance
DALFAMPRIDINE
Active strength
10 mg/1
Pharmacologic classes
Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A206863-001DALFAMPRIDINEDALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A206863-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-111e350fbaab3a…
2024-05-31 18:47 UTC2024-05A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-118072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-115c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-115d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-114b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-1174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-1187673890dc5c…
2021-03-12 10:30 UTC2021-03A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-115aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-118869cabd3fbd…
2020-11-12 02:37 UTC2020-11A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11c0c555d07b60…
2019-12-14 00:12 UTC2019-12A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-113f01610625f2…
2019-09-15 20:21 UTC2019-09A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11b00525d2431f…
2019-07-19 19:46 UTC2019-07A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-116a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-111c564ffb4f44…
2023-12-20 04:57 UTC2023-12A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-119b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-113f0d92c62455…
2023-05-13 08:27 UTC2023-05A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11053a50430f4f…
2023-01-26 05:58 UTC2023-01A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-113bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-113a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A206863-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-11e64feba35796…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A206863-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A206863-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206863-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A206863-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206863-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206863-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206863-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206863-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206863-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206863-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A206863-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206863-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A206863-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A206863-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A206863-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A206863-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A206863-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A206863-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A206863-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A206863-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A206863-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A206863-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A206863-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A206863-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A206863-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A206863-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A206863-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A206863-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A206863-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A206863-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A206863-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A206863-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A206863-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A206863-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A206863-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A206863-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A206863-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A206863-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A206863-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A206863-001AB1e64feba35796…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2019-12-13 00:20 UTC2019-12A206863-001PC2019-03-0974a2ff9319b5…
2019-12-14 00:12 UTC2019-12A206863-001PC2019-03-093f01610625f2…
2019-09-15 20:21 UTC2019-09A206863-001PC2019-03-09b00525d2431f…
2019-07-19 19:46 UTC2019-07A206863-001PC2019-03-09ea99ee380514…

Additional Listing Data#

Finished product
Yes
Brand name base
Dalfampridine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DALFAMPRIDINE10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
BH3B64OKL9Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
897021Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
354a97e8-35c8-418b-91b2-9e8e066cec65Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9109832c-cb3c-b72f-db80-0e6688f08431Product name520190619

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
16729-292-01Dalfampridine100 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE1008
16729-292-10Dalfampridine30 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE308
16729-292-12Dalfampridine60 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE608
16729-292-16Dalfampridine500 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE5008
16729-292-17Dalfampridine1000 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE10008

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
16729-292-12EA - Each16729-292dd5d33c9-fb5a-43ab-a03a-8976b2c8d1d412018-10-11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
16729-292DALFAMPRIDINE TABLET, FILM COATED, EXTENDED RELEASE [ACCORD HEALTHCARE INC.]7Current NDC, Legacy NDC, 5 package rows20240105_354a97e8-35c8-418b-91b2-9e8e066cec65.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DalfampridineDALFAMPRIDINEAccord Healthcare Inc.354a97e8-35c8-418b-91b2-9e8e066cec652025-10-09Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206863
application number: ANDA206863
ndc (product): 16729-292

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
897021dalfampridine 10 MG 12HR Extended Release Oral TabletPSN354a97e8-35c8-418b-91b2-9e8e066cec658
89702112 HR dalfampridine 10 MG Extended Release Oral TabletSCD354a97e8-35c8-418b-91b2-9e8e066cec658
897021dalfampridine 10 MG 12 HR Extended Release Oral TabletSY354a97e8-35c8-418b-91b2-9e8e066cec658

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
16729-292-0116729029201100 in 1 BOTTLEHistorical
16729-292-101672902921030 in 1 BOTTLEHistorical
16729-292-121672902921260 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16729-292-12) 2018-09-180000-00-00NoNoCurrent
16729-292-1616729029216500 in 1 BOTTLEHistorical
16729-292-17167290292171000 in 1 BOTTLEHistorical